Methylation of Notch3 modulates chemoresistance via P-glycoprotein

Xiaoting Gu1, Yangfan Lu1, Dongxu He2

  • 1School of Pharmaceutical Sciences, Jiangnan University, 1800 Lihu Rd, Wuxi, Jiangsu 214122, China.

Insights

Epigenetic silencing of the Notch3 gene via DNA hypermethylation inactivates this tumor suppressor in adriamycin-resistant breast cancer cells. This leads to increased P-glycoprotein expression, contributing to drug resistance.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • Chemoresistance in breast cancer is a significant clinical challenge.
  • DNA methylation patterns are altered in chemoresistant cells, affecting gene expression and cellular characteristics.
  • Understanding the epigenetic mechanisms underlying drug resistance is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the role of DNA methylation in adriamycin resistance in human breast cancer cells (MCF-7/ADM).
  • To identify specific genes affected by epigenetic alterations in chemoresistant cells.
  • To elucidate the relationship between gene methylation, tumor suppressor gene inactivation, and drug efflux pump expression.

Main Methods:

  • Comparative analysis of gene expression and DNA methylation in adriamycin-resistant (MCF-7/ADM), paclitaxel-resistant (MCF-7/PTX), and wild-type (MCF-7) breast cancer cells.
  • Investigation of epigenetic silencing of the tumor-suppressor gene Notch3 through DNA hypermethylation.
  • Assessment of the regulatory relationship between Notch3 and the drug efflux pump P-glycoprotein.

Main Results:

  • Global gene expression and DNA methylation profiles of MCF-7/ADM cells closely resemble MCF-7/PTX cells and differ significantly from wild-type MCF-7 cells.
  • The tumor-suppressor gene Notch3 was found to be epigenetically silenced by DNA hypermethylation in MCF-7/ADM cells.
  • Notch3 negatively regulates P-glycoprotein, which was highly expressed in MCF-7/ADM cells, indicating Notch3 inactivation contributes to its upregulation.

Conclusions:

  • DNA hypermethylation of the Notch3 gene is a key mechanism for its inactivation in adriamycin-resistant breast cancer cells.
  • Inactivation of Notch3 leads to the activation and high expression of the P-glycoprotein drug efflux pump.
  • These findings highlight the critical role of epigenetic modifications in mediating chemoresistance and suggest potential therapeutic targets.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.8K
Notch Signaling Pathway03:14

Notch Signaling Pathway

6.4K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.1K